News
Brand Powerhouse | The 2022 China Brand Value Evaluation Report Reveals: Wanbangde Pharmaceutical Group Named on the List of Independently Innovative Brands!
Date:
15 Oct,2022
Recently, the China Brand Building Promotion Association, the China Association of Asset Appraisers, the Xinhua News Agency’s National Brand Project Office, and other organizations jointly released the "2022 China Brand Value Evaluation Information" in Beijing. Based on relevant national standards for brand value assessment, the information was determined after expert review, calculations by technical institutions, and approval by the Brand Evaluation and Release Committee. Wanbangde Pharmaceutical Group Co., Ltd.'s independently developed brand boasts a brand strength of 727 and a brand value of 1.512 billion yuan.
It is reported that the non-profit "China Brand Value Evaluation Information Release," jointly organized by the China Brand Building Promotion Association and relevant authoritative institutions, has been held annually for the past nine years. This initiative plays a vital role in establishing a brand-value evaluation system with Chinese characteristics, fostering positive energy for Chinese brands, and helping Chinese brands gain global recognition.
Founded in 1970, Wanbangde Pharmaceutical Group is a high-tech enterprise dedicated to the research, development, manufacturing, and marketing of modern Chinese medicine, as well as chemical APIs and pharmaceutical preparations. Today, the company has established a product portfolio characterized by natural herbal medicines, with a primary focus on cardiovascular, cerebrovascular, and nervous system medications, complemented by therapies for respiratory and other therapeutic areas. Its products span multiple treatment fields, including cardiovascular and cerebrovascular diseases, neurological disorders, respiratory conditions, and digestive system ailments. As a leading Chinese pharmaceutical brand, Wanbangde Pharmaceutical Group remains steadfastly committed to product quality, leveraging its unique "raw materials + formulations" advantage to continuously push the boundaries of expertise and unlock new opportunities for business growth.
Brand power drives innovation, and strength builds brilliance. Moving forward, Wanbangde Pharmaceutical Group will leverage innovation as its core engine to further strengthen our brand identity, enhance the influence and awareness of our own brands, and contribute actively to continuously amplifying the powerful voice of China’s leading brands!
Related Recommendations